Clinical Trial Update: Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder [Phase 3]

View source ↗

Summary

An extension Phase 3 trial assessing safety and tolerability of flexible doses of oral ziprasidone in children and adolescents with Bipolar I Disorder was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: TERMINATED | Results posted: 2021-04-27